An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis

Area of Science:

• Infectious Diseases
• Mycology
• Critical Care Medicine

Background:

• Rhinocerebral mucormycosis is a severe fungal infection primarily affecting immunocompromised individuals, including those with uncontrolled diabetes, organ transplants, and hematologic malignancies.
• The infection typically originates in the paranasal sinuses and can rapidly spread intracranially, leading to high mortality rates (up to 85%) despite comprehensive treatment.

Purpose of the Study:

• To evaluate the effectiveness of an aggressive, multidisciplinary treatment strategy for rhinocerebral mucormycosis.
• To analyze patient outcomes based on early surgical intervention, antifungal therapy, and management of underlying conditions.

Main Methods:

• A retrospective chart review was conducted on patients diagnosed with rhinocerebral mucormycosis between 2011 and 2014.
• Data collected included patient symptoms, surgical and medical management details, and treatment outcomes.
• Four patients were identified and analyzed for their response to rapid, aggressive surgical debridement and prompt antifungal therapy.

Main Results:

• The study observed a 50% mortality rate among the treated patients, indicating a potential improvement compared to historical rates.
• Early and aggressive surgical debridement, combined with antifungal therapy initiated on the day of diagnosis, was a key component of management.

Conclusions:

• An early, aggressive, multidisciplinary approach involving otolaryngology, neurosurgery, ophthalmology, infectious disease, and critical care specialists can improve survival in rhinocerebral mucormycosis.
• Despite improved outcomes with this strategy, the disease remains largely fatal, necessitating a high index of suspicion in at-risk populations for rapid intervention.